United Therapeutics Corporation

Equities

UTHR

US91307C1027

Market Closed - Nasdaq Other stock markets 21:00:00 16/01/2026 GMT			5-day change	1st Jan Change
464.93 ^USD	-1.50%		-3.79%	-4.58%

01-15	United Therapeutics Insider Sold Shares Worth $3,900,122, According to a Recent SEC Filing	MT
01-12	United Therapeutics Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 01:30 PM

Transcript : United Therapeutics Corporation, Q3 2025 Earnings Call, Oct 29, 2025

Published on 10/29/2025 at 02:21 pm GMT - Modified on 10/29/2025 at 04:05 pm GMT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good morning, everyone, and welcome to the United Therapeutics Corporation Third Quarter 2025 Corporate Update. My name is Jamie, and I will be your

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about United Therapeutics Corporation

01-15	United Therapeutics Insider Sold Shares Worth $3,900,122, According to a Recent SEC Filing	MT
01-12	United Therapeutics Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 01:30 PM
01-07	SAB Biotherapeutics, Inc. Announces Board Changes ,Effective January 7, 2026	CI
01-06	UBS Adjusts Price Target on United Therapeutics to $645 From $600, Maintains Buy Rating	MT
01-05	United Therapeutics Insider Sold Shares Worth $500,015, According to a Recent SEC Filing	MT
12-29	United Therapeutics Insider Sold Shares Worth $11,572,963, According to a Recent SEC Filing	MT
12-29	United Therapeutics Insider Sold Shares Worth $5,644,954, According to a Recent SEC Filing	MT
12-23	United Therapeutics Insider Sold Shares Worth $3,047,201, According to a Recent SEC Filing	MT
12-16	United Therapeutics Insider Sold Shares Worth $3,952,689, According to a Recent SEC Filing	MT
12-16	United Therapeutics Insider Sold Shares Worth $1,742,193, According to a Recent SEC Filing	MT
12-16	United Therapeutics Insider Sold Shares Worth $11,166,722, According to a Recent SEC Filing	MT
12-10	United Therapeutics Insider Sold Shares Worth $3,833,374, According to a Recent SEC Filing	MT
12-09	United Therapeutics Insider Sold Shares Worth $10,050,597, According to a Recent SEC Filing	MT
12-08	United Therapeutics Insider Sold Shares Worth $3,870,056, According to a Recent SEC Filing	MT
12-05	United Therapeutics Insider Sold Shares Worth $3,821,130, According to a Recent SEC Filing	MT
12-02	United Therapeutics Insider Sold Shares Worth $10,798,079, According to a Recent SEC Filing	MT
12-02	United Therapeutics Insider Sold Shares Worth $3,852,846, According to a Recent SEC Filing	MT
12-02	United Therapeutics Insider Sold Shares Worth $10,079,696, According to a Recent SEC Filing	MT
11-25	United Therapeutics Insider Sold Shares Worth $3,784,419, According to a Recent SEC Filing	MT
11-21	United Therapeutics Insider Sold Shares Worth $3,812,082, According to a Recent SEC Filing	MT
11-20	United Therapeutics Insider Sold Shares Worth $3,789,373, According to a Recent SEC Filing	MT
11-18	United Therapeutics Corporation Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 12:00 PM
11-14	United Therapeutics Insider Sold Shares Worth $4,755,854, According to a Recent SEC Filing	MT
11-13	United Therapeutics Insider Sold Shares Worth $5,112,335, According to a Recent SEC Filing	MT
11-12	United Therapeutics Insider Sold Shares Worth $3,600,830, According to a Recent SEC Filing	MT